Latest Recursion News & Updates

See the latest news and media coverage for Recursion. We track all announcements, press releases, and industry mentions in real time, all in one place.

Recursion

AI-driven drug discovery company

recursion.com

Headquarters: Salt Lake City, United States
Founded year: 2013
Company type: Public company
Number of employees: 700–1,000
Industry: Pharmaceuticals

Last updated Today

Latest news about Recursion

In short: Recursion advanced its Genentech partnership, missed Q2 financial estimates, and underwent executive transitions under CEO Najat Khan.

Company announcements

August 5 Recursion

Recursion and Genentech advance first neuroscience target into program

The target passed pathway, functional, and disease validation from an AI-driven neuron map built from over 1 trillion cells; it now enters small molecule hit generation.

April 29 Recursion

Recursion to report Q1 2026 results on May 6

Company will host earnings call at 8:00 am ET with webcast and public Q&A.

February 25 Recursion

Recursion reports fourth quarter and full year 2025 financial results

The company achieved key milestones including clinical validation in FAP and a fifth milestone with Sanofi, with $754M cash on hand.

February 5 Recursion

Recursion integrates data layers to advance end-to-end drug discovery

The company's platform combines phenomics, transcriptomics, and patient data via foundation models for novel drug development.

Media coverage

Today StocksToTrade

These Are the Stocks Wall Street Is Betting Against the Most

The supplied source only contains the heatmap headline and ticker list, without the underlying...

Never miss news about Recursion

Track Recursion and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Recursion competitors & trending companies

Browse news for competitors to Recursion and other trending companies.